'On track to be­come a block­buster': FDA ap­proves in­jectable form of ar­genx's au­toim­mune drug

The Dutch biotech com­pa­ny ar­genx won FDA ap­proval on Tues­day for an eas­i­er-to-ad­min­is­ter ver­sion of its au­toim­mune dis­ease drug ef­gar­tigi­mod. The new ver­sion, mar­ket­ed at …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER